In contrast, domain 13, with high expression of MGP, CPB1, and S100G, points to a region associated with calcification, ECM remodeling, and tumor progression, which may contribute to treatment resistance and poor clinical outcomes. The gene discussed is CPB1; the disease is neoplasm.